J&J investors sue for mismanagement; YouTube adds safe meds channel;

> J&J shareholders have asked a judge to find mismanagement among directors and top executives and order them to pay damages. Article

> Novartis will build a $36 million research lab and create 100 new high-paying jobs in Holly Springs, NC, where it opened a vaccine plant last year. Story

> After seven months of trying, the Pasteur Institute of India at Coonoor has failed to manufacture enough DPT vaccine to meet National Immunization Program requirements. Article

> The Partnership for Safe Medicines has launched a Safe Medicines YouTube Channel. Videos

> GAR Labs has been cited in FDA Warning Letter for failing to comply with a QC unit recommendation to destroy an acne drug products for failing assay results three times; management directed that lots be reworked to pass inspection. Warning Letter 15-11

> U.S. Representatives have introduced a bill to upgrade "out-of-date" prescription drug safety laws. Article

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.